Pharmacy Medical News about Economic Burden

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Direct Economic Burden of High-Risk and Metastatic Melanoma in the Elderly: Evidence from the SEER-Medicare Linked Database
Applied Health Economics and Health Policy, 07/07/09

Davis KL et al. - The per-patient cost of advanced melanoma is high. Hospital services are the largest component of these costs. Monthly costs for subjects with stage IV melanoma were 67% higher than costs for subjects with stage IIIC disease and >3-fold higher than costs for patients with stages IIIA/B and IIB/C. However, when combining estimated monthly costs with median follow-up duration (a proxy for survival time), total costs incurred by Medicare appear to be highest for patients diagnosed at stage IIIA/B.

<< Previous
Successful phase II/III trial of new therapy for adrenal...

Next >>
A Comparison of Long- and Short-Acting Opioids for the Treatment...

Forecasting the Future Economic Burden of Current Adolescent Overweight: An Estimate of the Coronary Heart Disease Policy Model
American Journal of Public Health, 10/28/09 Relevance Score: 67%

Hospital-based study of the severity and economic burden associated with rotavirus diarrhea in Sri Lanka
Journal of Pediatric Infectious Diseases, 11/02/09 Relevance Score: 66%

Are malaria treatment expenditures catastrophic to different socio-economic and geographic groups and how do they cope with payment? A study in southeast Nigeria
Tropical Medicine & International Health, 11/11/09 Relevance Score: 65%

The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review
Expert Opinion in Pharmacotherapy, 11/03/09 Relevance Score: 65%

Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy
Current Medical Research and Opinion, 10/30/09 Relevance Score: 65%